Wanting to start a business is a noble idea, especially in the ever-growing field f Biotechnology. However, it requires one to prepare many things for smooth running. One of them includes preparing pitch decks. Pitch decks are a type of presentation by company owners to present their ideas to investors.
This type of deck can be a little difficult to tackle.
This article describes 7 Pitch Decks from Successful Biotechnology Startups below to give a basic idea of pitch decks used in these sectors.
1. Theranos
Theranos is a consumer healthcare technology that works on preventing, detecting, and curing blood-borne diseases.
This company works primarily via E-Commerce. The customer interaction of this company is Business-to-Government (B2G) and Business-to-Business-to-Consumer (B2B2C).
Theranos was founded in 2006 and is currently a series C company. Major investors for Theranos are Venture capital and corporate, and it has collected $28.5M so far.
2. Healx
Healx is an innovative company changing how patients and doctors treat rare diseases. They have been doing so by generating insights and providing recommendations that help in the outcome.
Westside for Bodybuilders proviron in bodybuilding watch a bodybuilder try to follow the ‘military diet’ for 72 hoursThis company works on Subscription bases. It mainly interacts with its clients via Business-to-Government (B2G) and Business-to-Business (B2B) interactions.
Healx has been in action since 2019. It has mostly venture capital as investors and has collected $56M so far. It is a series B company.
3. Folia Water
Folia Water is an environmentally conscious company working on producing high-performance fibers that can be mass-produced at a lower cost at paper mills with conventional machinery.
This company works with its unspecified marketplace following the Business-to-Business-to-Consumer (B2B2C) pattern.
Founded in 2017, Folia Water is a seed-stage company that has raised $159K with venture capital as investors.
4. ELXR
ELXR is a cloud sports club that presents its user’s data in one place, allowing more accessible insight for the user.
This is an app, and it interacts with its consumers via the Customer-to-Customer (C2C) pattern.
This company was established in 2018 and is at the seed stage of marketing. No details regarding the investors and funding can be found until now.
5. Qualio
This platform helps one compare all the stages of development regarding Life Science Companies.
It is Software as a Service (SaaS), and its primary clientele comprises businesses that interact via Business-to-Business patterns (B2B).
It has been active since 2015 and is now at the seed level. It has raised about $125K and its investors as Venture capital.
6. Fyodor Biotechnologies
This company provides innovative medical devices for the public.
It accesses its marketplace via E-Commerce. It connects its clientele via a Business-to-Consumer (B2C) pattern.
Founded in 2018, this company is at the seed stage. No details about their investors or funding are available for viewing.
7. Cyclica
Cyclica gives tools necessary for pre-clinical drug discovery.
Software as a Service reaches most clientele via Business-to-Business (B2B) and Business-to-Government (B2G) patterns.
This company was founded recently in 2020. It is a series B company with Venture capital as an investment, and it has collected $17M until now.
